Resistance to diet-induced obesity and associated metabolic perturbations in haploinsufficient monocarboxylate transporter 1 mice

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lengacher, Sylvain ^a,b   Nehiri Sitayeb, Touria ^a   Steiner, Nadia ^a   Carneiro, Lionel ^a   Favrod, Céline ^a   Preitner, Frédéric ^a   Thorens, Bernard ^a   Stehle, Jean Christophe ^c   Dix, Laure ^c   Pralong, François ^d   Magistretti, Pierre J ^b   Pellerin, Luc ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; MONOCARBOXYLATE TRANSPORTER 1; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; ENERGY ABSORPTION; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; GLUCOSE INTOLERANCE; HAPLOINSUFFICIENCY; HOMOZYGOSITY; INSULIN RESISTANCE; INTESTINE ABSORPTION; LIPID METABOLISM; LIPID STORAGE; MALE; MCT1 GENE; METABOLIC RATE; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PHENOTYPE; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ANIMALS; BETA-GALACTOSIDASE; BODY COMPOSITION; DIET, HIGH-FAT; EATING; FEMALE; MALE; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MONOCARBOXYLIC ACID TRANSPORTERS; OBESITY; SYMPORTERS;

EID: 84893177634     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082505     Document Type: Article

References (49)

1. Gertz EW, Wisneski JA, Stanley WC, Neese RA (1988) Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest 82:2017-2025. (Pubitemid 19054950)
2. van Hall G, Strømstad M, Rasmussen P, Jans O, Zaar M, et al. (2009) Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab 29:1121-1129.
3. Brooks GA (1986) The lactate shuttle during exercise and recovery. Med Sci Sports Exerc 18:360-368.
4. Katz J, Wals P, Lee WN (1993) Isotopomer studies of gluconeogenesis and the Krebs cycle with 13C-labeled lactate. J Biol Chem 268:25509-25521. (Pubitemid 23358158)
5. Ainscow EK, Mirshamsi S, Tang T, Ashford ML, Rutter GA (2002) Dynamic imaging of free cytosolic ATP concentration during fuel sensing by rat hypothalamic neurones: evidence for ATP-independent control of ATP-sensitive K(+) channels. J Physiol 544:429-445. (Pubitemid 35244260)
6. Cha SH, Lane MD (2009) Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway. Biochem Biophys Res Commun 386:212-216.
7. Kokorovic A, Cheung GW, Rossetti L, Lam TK (2009) Hypothalamic sensing of circulating lactate regulates glucose production. J Cell Mol Med 13:4403-4408.
8. Fukao T, Lopaschuk GD, Mitchell GA (2004) Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 70:243-251. (Pubitemid 38200951)
9. Sunny NE, Satapati S, Fu X, He T, Mehdibeigi R, et al. (2010) Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. Am J Physiol 298:E1226-E1235.
10. Morris AA (2005) Cerebral ketone body metabolism. J Inherit Metab Dis 28:109-121.
11. Ziegler A, Zaugg CE, Buser PT, Seelig J, Künnecke B (2002) Non-invasive measurements of myocardial carbon metabolism using in vivo 13C NMR metabolism. NMR Biomed 15:222-234. (Pubitemid 34520662)
12. Winder WW, Baldwin KM, Holloszy JO (1975) Exercise-induced increase in the capacity of rat skeletal muscle to oxidize ketones. Can J Physiol Pharmacol 53: 86-91.
13. Laeger T, Metges CC, Kuhla B (2010) Role of beta-hydroxybutyric acid in the regulation of energy balance. Appetite 54: 450-453.
14. Park S, Kim da S, Daily JW (2011) Central infusion of ketone bodies modulates body weight and hepatic insulin sensitivity by modifying hypothalamic leptin and insulin signaling pathways in type 2 diabetic rats. Brain Res 1401:95-103.
15. van Dyken R, Hubold C, Meier S, Hitze B, Marxsen A, et al. (2010) Low plasma lactate concentration as a biomarker of an incompetent brain-pull: a risk factor for weight gain in type 2 diabetes patients. Psychoneuroendocrinology 35:1287-1293.
16. Triscari J, Greenwood MR, Sullivan AC (1982) Oxidation and ketogenesis in hepatocytes of lean and obese Zucker rats. Metabolism 31:223-228. (Pubitemid 12176909)
17. Pierre K, Pellerin L (2005) Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem 94:1-14. (Pubitemid 40911387)
18. Hajduch E, Heyes RR, Watt PW, Hundal HS (2000) Lactate transport in rat adipocytes: identification of monocarboxylate transporter 1 (MCT1) and its modulation during streptozotocin-induced diabetes. FEBS Lett 479:89-92. (Pubitemid 30616412)
19. Iwanaga T, Takebe K, Kato I, Karaki S, Kuwahara A (2006) Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8. Biomed Res 27:243-254. (Pubitemid 44768653)
20. McCullagh KJ, Poole RC, Halestrap AP, O'Brien M, Bonen A (1996) Role of the lactate transporter (MCT1) in skeletal muscles. Am J Physiol 271:E143-E150.
21. Mansour SL, Thomas KR, Capecchi MR (1988) Disruption of the protooncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352.
22. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
23. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, et al. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8:711-713. (Pubitemid 127739700)
24. Jang C, Lee G, Chung J (2008) LKB1 induces apical trafficking of Silnoon, a monocarboxylate transporter, in Drosophila melanogaster. J Cell Biol 183:11-17.
25. Nagai A, Takebe K, Nio-Kobayashi J, Takahashi-Iwanaga H, Iwanaga T (2010) Cellular expression of the monocarboxylate transporter (MCT) family in the placenta of mice. Placenta 31:126-133.
26. Maekawa F, Minehira K, Kadomatsu K, Pellerin L (2008) Basal and stimulated fluxes in primary cultures of astrocytes are differentially controlled by distinct proteins. J Neurochem 107:789-798.
27. Collins S, Martin TL, Surwit RS, Robidoux J (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81:243-248. (Pubitemid 38670090)
28. Tabarin A, Diz-Chaves Y, Carmona Mdel C, Catargi B, Zorrilla EP, et al. (2005) Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene". Diabetes 54:3510-3516. (Pubitemid 43334343)
29. Mercader J, Ribot J, Murano I, Feddersen S, Cinti S, et al. (2009) Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice. Am J Physiol Endocrinol Metab 297:E184-E193.
30. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, et al. (1999) PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609. (Pubitemid 29531139)
31. Zadravec D, Brolinson A, Fisher RM, Carneheim C, Csikasz RI, et al. (2010) Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J 24:4366-4377.
32. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28:640-648. (Pubitemid 38491158)
33. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, et al. (2001) Partial leptin deficiency and human adiposity. Nature 414:34-35. (Pubitemid 33041612)
34. Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, et al. (2003) Obesity due to proopiomelanocortin deficiency: three cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 88:4633-4640. (Pubitemid 37357504)
35. Ritzhaupt A, Wood IS, Ellis A, Hosie KB, Shirazi-Beechey SP (1998) Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport L-lactate as well as butyrate. J Physiol 513:719-732. (Pubitemid 29008104)
36. Zambell KL, Fitch MD, Fleming SE (2003) Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J Nutr 133:3509-3515. (Pubitemid 37409480)
37. Alvaro A, Solà R, Rosales R, Ribalta J, Anguera A, et al. (2008) Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB Life 60:757-764.
38. Morrison CD, Huypens P, Stewart LK, Gettys TW (2009) Implications of crosstalk between leptin and insulin signaling during the development of diet induced obesity. Biochim Biophys Acta 1792:409-416.
39. Shi Y, Burn P (2004) Lipid metabolic enzymes: emerging drug targets for the tretment of obesity. Nat Rev Drug Discov 3:695-710. (Pubitemid 39173510)
40. Powell DR (2006) Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo. Obes Rev 7:89-108.
41. Johnson AMF, Olefsky JM (2013) The origins and drivers of insulin resistance. Cell 152:673-684.
42. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, et al. (2001) Perilipin ablation results in a lean mouse with aberrant lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 98:6494-6498.
43. Vergnes L, Beigneux AP, Davis R, Watkins SM, Young SG, et al. (2006) Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity. J Lipid Res 47:745-754.
44. Kim EJ, Kim E, Kwon EY, Jang HS, Hur CG, et al. (2010) Network analysis of hepatic genes responded to high-fat diet in C57BL/6J mice : nutrigenomics data mining from recent research findings. J Med Food 13 :743-756.
45. Stramble MS, Ntambi JM (2010) Genetic control of de novo lipogenesis : role in diet-induced obesity. Crit Rev Biochem Mol Biol 45:199-214.
46. Yu XX, Murray SF, Pandey SK, Booten SL, Bao D, et al. (2005) Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 42:362-371. (Pubitemid 41061089)
47. Koonen PY, Jacobs RL, Febbraio M, Young ME, Soltys CLM, et al. (2007) Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 56:2863-2871. (Pubitemid 350223619)
48. Frederico MJS, Vitto MF, Cesconetto PA, Engelmann J, De Souza DR, et al. (2011) Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. Scand J Gastroenterol 46:1381-1388.
49. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, et al. (2001) The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 276 :41245-41254.